Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-24

Clinical Trial Update: Adipose-derived SVF for Treatment of Erectile Dysfunction (ED) [NA]

View source ↗

Summary

A clinical trial evaluating adipose-derived stromal vascular fraction (SVF) for erectile dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adipose-derived stromal vascular fraction (SVF) (adipose-derived stromal vascular fraction)

Snippet

Sponsor: GID BIO, Inc. | Conditions: Erectile Dysfunction | NA | Status: WITHDRAWN